Triple-negative breast cancer (TNBC) makes up about 10% to 15% of breast cancer diagnoses and tends to be more aggressive than other breast cancers.
Dr. Foluso Ademuyiwa answers questions about symptoms, side-effects, and treatment options for early-stage and metastatic TNBC.
On this page
About our speaker


Foluso Olabisi Ademuyiwa (Bisi), MD, MPH, MSCI
Foluso Olabisi Ademuyiwa (Bisi), MD, MPH, MSCI, is a breast medical oncologist and associate professor at Washington University in St. Louis. She is an expert in the management of all types of breast cancer. She provides patient-centered care as part of a multidisciplinary breast cancer team. Dr. Ademuyiwa is actively involved in research on triple-negative breast cancer and racial disparities in breast cancer research and serves as principal investigator on multiple clinical trials.
Learn moreThank you to our sponsors
Signature
Benefactor